- Product Details
Keywords
- Entecavir
- 142217-69-4
- entecavir (anhydrous)
Quick Details
- ProName: Entecavir
- CasNo: 142217-69-4
- Molecular Formula: C12H15N5O3
- Appearance: white powder
- Application: pharmaceuticla raw materials
- DeliveryTime: With three or five working days
- PackAge: 25kg/fiber drum, sealed package
- Port: China main port
- ProductionCapacity: 10 Metric Ton/Month
- Purity: 99.9%
- Storage: Sealed package
- Transportation: Sealed package, keep away from light
- LimitNum: 1 Metric Ton
- Valid Period: 2020-12-18
Superiority
1. Advanced facility and Equipment
2. Competent technical team
3 .Strong R & D support
4,high quality products with high stability
5, Competitive price
5.Customer tailored service
Details
Product Name: Entecavir
Chemical Name: 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylidene-cyclopentyl]-3H-purin-6-one
Cas No.: 142217-69-4
Molecular Formula: C12H15N5O3
Molecular Weight: 295.3
Entecavir is an oral antiviral drug used in the treatment of hepatitis B infection. Entecavir is a nucleoside analog (more specifically, a guanosineanalogue) that inhibits reverse transcription, DNA replication and transcription in the viral replication process. The drug's manufacturer claims that entecavir is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir). It also helps prevent the hepatitis B virus from multiplying and infecting new liver cells. Entecavir is also indicated for the treatment of chronic hepatitis B in adults with HIV/AIDS infection.